2012 業績紹介

2012年

1. 成人および高齢者の精神・神経疾患の認知神経科学的研究

－総説－

  1. Kikuchi K, Uchikado H, Morioka M, Murai Y, Tanaka E: Clinical neuroprotective drugs for treatment and prevention of stroke. Int J Mol Sci 2012;13: 7739-7761.
  2. Kikuchi K, Miura N, Kawahara K, Murai Y, Morioka M, Lapchak P, Tanaka E: Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke (Review). Biomedical Reports 2013;1:7-12.

－論文－

  1. Uchimura N,Kamijo A, Takase T: Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study. Ann Gen Psychiatry 2012;11(15):1-15.
  2. Ohtsu T, Kaneita Y，Aritake S,Mishima K, Uchiyama M, Akashiba T, Uchimura N, Nakaji S,Munezawa T,Shimada N,Kokaze A,Ohida T: Preferable forms of relaxation for health promotion, and the association between recreational activities and self-perceived health. Acta Medica Okayama 　2012;66(1):41-51.
  3. Mori K, Morita K, Shoji Y, Matsuoka T, Fujiki R, Uchimura N: State and trait markers of emotional charged visual event-related potentials (P300)in drug-naive schizophrenia. Psychiatry Clin Neurosci 2012 Jun;66(4):261-269.
  4. Ito K, Kawayama T, Shoji Y,Fukushima N,Matsunaga K, Edakuni N, Uchimura N, Hoshino T: Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease. Respirology 2012;17:940-949.
  5. Ishii Y, Morita K, Shoji Y, Kawabe C, Fujiki R, Inoue M, Uchimura N: Left eye scanning deficit in schizophrenia patients under emotional loading task: Comparison with healthy controls. Kurume Med J 2012;59(1･2):17-24.
  6. Miura S, Kida H, Nakajima J, Noda K, Nagasato K, Ayabe M, Aizawa H, Hauser M, Taniwaki T:Anhedonia in Japanese patients with Parkinson's disease: Analysis using the Snaith-Hamilton Pleasure Scale. Clin Neurol Neurosurg. 2012 May;114(4):352-355.
  7. Oe M, U Schnyder, S Schumacher, C Mueller-Pfeiffer, F. H. Wilhelm, N Kalebasi, D Roos, M Hersberger, C Martin-Soelch : Lower Plasma Dehydroepiandrosterone Concentration in the Long Term after Severe Accidental Injury. Psychother Psychosom　2012;81:121-123.
  8. Okubo H, Miyake Y, Sasaki S, Murakami K, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M: Fukuoka Kinki Parkinson’s Disease Study Group (Collaborators; Taniwaki T). Dietary patterns and risk of Parkinson's disease: a case-control study in Japan. Eur J Neurol 2012 May;19 (5):681-688.
  9. Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M: Fukuoka Kinki Parkinson's Disease Study Group (Collaborators; Taniwaki T). SNCA polymorphisms, smoking, and sporadic Parkinson's disease in Japanese. Parkinsonism Relat Disord 2012 Jun;18 (5):557-561.
  10. Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M: Fukuoka Kinki Parkinson's Disease Study Group (Collaborators; Taniwaki T). Lack of association between BST1 polymorphisms and sporadic Parkinson's disease in a Japanese population. J Neurol Sci 2012 Dec 15;323(1-2):162-166.
  11. Okamoto Y, Takano M, Ohba T, Ono K: Arrhythmogenic coupling between the Na+-Ca2+ exchanger and inositol 1,4,5-triphosphate receptor in rat pulmonary vein cardiomyocytes. J Mol Cell Cardiol 2012;52(5):988-997.
  12. Cui H, Mason BL, Lee C, Nishi A, Elmquist JK, Lutter M：Melanocortin 4 receptor signaling in dopamine 1 receptor neurons is required for procedural memory learning. Physiol Behav 2012;106(2):201-210.
  13. Kuroiwa M, Hamada M, Hieda E, Shuto T, Sotogaku N, Flajolet M, Snyder GL, Hendrick JP, Fienberg A, Nishi A: Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons. Neuropharmacology 2012;63(7):1248-1257.
  14. Kawahara Y, Kaneko F, Yamada M, Kishikawa Y, Kawahara H, Nishi A: Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system. Neuropharmacology 2013;67:395-402.
  15. Murai Y,Okabe Y,Tanaka E: Activation of protein kinase A and C prevents recovery from persistent depolarization produced by oxygen and glucose deprivation in rat hippocampal neurons. J Neurophysiol 2012;107:2517-2525.
  16. Okabe Y,Takahashi T, Mitsumasu C, Kosai K, Tanaka E, Matsuishi T: Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS ONE 2012;7(4):e35354.
  17. Shuto T, Kuroiwa M, Koga Y, Kawahara Y, Sotogaku N, Toyomasu K, Nishi A: Acute effects of resveratrol to enhance cocaine-induced dopamine neurotransmission in the striatum. Neuroscience Letters 2013;542:107-112.
  18. Tanoue S, Kiyosue H, Hori Y, Abe T, Mori H: Turn-Back embolization technique for effective transvenous embolization of dural arteriovenous fistulas. AJNR Am J Neuroradiol 2012;33:E88-91.
  19. Takemoto Y, Morioka M, Nakagawa T, Hasegawa Y, Ohmori Y, Kawano T, Kai Y, Kuratsu J: Prolonged and regionally progressive symptomatic cerebral hyperperfusion syndrome after superficial temporal artery middle cerebral artery anastomosis in a patient with moyamoya disease. Surg Neurol Int 2012:3:106.
  20. Aoki T, Yoshitomi M, Yamamoto M, Hirohata M, Morioka M: Ruptured de novo aneurysm arising at a site remote from the anastomosis 14 years after superficial temporal artery-middle cerebral artery bypass: A case report. Neurosurgery 2012:71(4): E905-E909.
  21. Kaku Y, Morioka M, Ohmori Y, Kawano T, Kai Y, Fukuoka H, Hirai T, Yamashita Y, Kuratsu J: Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir(Wien). 2012:154(12):2151-2157.
  22. Honda Y, Tsuda A, Horiuchi S: Effect of a four-week self-administrered acupressure interbention on perceived stress over the past month. Open Journal of Medical Psychology 2012;1:20-24.
  23. Honda Y, Tsuda A, Horiuchi S: Validity of the neck meridian test as a measure of stress. Open Journal of Medical Psychology 2012;1:81-85.
  24. Tsunoda T,Kanba S,Ueno T,Hirano Y,Hirano S, Maekawa T, Onitsuka T：Altered face inversion effect and association between face N170 reduction and social dysfunction in patients with schizophrenia. Clin Neurophysiol 2012 Sep;123(9):1762-1768.
  25. Oda Y, Onitsuka T, Tsuchimoto R, Hirano S, Oribe N, Ueno T, Hirano Y,Nakamura I, Miura T, Kanba S: Gamma band neural synchronizationdeficits for auditory steady state responses in bipolar disorder patients. PLoS ONE 2012:e39955.
  26. Nakano M, Yamamoto T, Okamura H, Tsuda A, Kowatari Y : Effects of oral supplementation with pyrroloquinoline quinone on stress, fatigue, and sleep. Functional Foods in Health and Disease 2012;2(8):307-324.

2. 成人および高齢者の精神・神経疾患の分子生物学的研究

－著書－

  1. Nishi Y, Mifune H, Kojima M: Ghrelin acylation by Ingestion of Medium-Chain Fatty Acids. 　Methods in Enzymology 514, 303-315 (Sep. 2012) (Elsevier press. Edited by Kojima M and Kangawa K)

－論文－

  1. Nakashima N, Yamashita　Y, Hirata R, Nagamitsu S, Matsuishi　T: Kana reading disability and Das-Naglieri Cognitive Assessment System findings in children with attention deficit hyperactivity disorder. Pediatr Int 2012 Dec;54(6):849-853.
  2. Fujimaru C,　Okamura H,　Kasaki M,　Kakuma T,　Yoshii C,　Matsuishi T: Self-perceived Work-related Stress and its Relation to Salivary lgA, Cortisol and 3-Methoxy- 4-hydroxyphenyl Glycol Levels among Neonatal Intensive Care Nurses. Stress Health 2012;(28):171-174.
  3. Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E, Matsuishi T: Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One 2012;7:e35354
  4. Matsuoka M, Nagamitsu S, Iwasaki M, Iemura A, Yamashita Y, Maeda M, Kitani S, Kakuma T, Uchimura N, Matsuishi T：High incidence of sleep problems in children with developmental disorders: Results of a questionnaire survey in a Japanese elementary school.　Brain Dev 2012(in press)
  5. Nagamitsu S, Yamashita Y, Tanaka H, Matsuishi T：Functional near-infrared spectroscopy studies in children.　 Biopsychosoc Med　2012;6:7.
  6. Ohya T, Yamashita Y, Shibuya I, Hara M, Nagamitsu S, Matsuishi T: Eyelid myoclonia with absences occurring during the clinical course of cryptogenic myoclonic epilepsy of early childhood.　 Eur J Paediatr Neurol　2012;16:399-401.
  7. Mizuochi T, Kimura A, Tanaka A, Muto A, Nittono H, Seki Y, Takahashi T, Kurosawa T, Kage M, Takikawa H, Matsuishi T: Characterization of urinary bile acids in a pediatric BRIC-1 patient: Effect of rifampicin treatment. Clin Chim Acta 2012;413:1301-1304.
  8. Yanagi T, Mizuochi T, Seki Y, Yagi M, Matsuishi T: Ulcerative colitis with rare chromosomal abnormalities: report of 2 patients. Inflamm Bowel Dis 2013 Apr;19(5):E68-69.
  9. Seki Y, Mizuochi T, Kimura A, Takahashi T, Ohtake A, Hayashi S, Morimura T, Ohno Y, Hoshina T, Ihara K, Takei H, Nittono H, Kurosawa T, Homma K, Hasegawa T, Matsuishi T: Two neonatal cholestasis patients with mutations in the SRD5B1 (AKR1D1) gene: diagnosis and bile acid profiles during chenodeoxycholic acid treatment.　J Inherit Metab Dis　2013 May;36(3):565-573.
  10. Koga Y, Povalko N, Nishioka J, Katayama K, Yatsuga S, Matsuishi T：Molecular Pathology of MELAS and L-arginine effects. Biochim Biophys Acta　2012;1820:608-614.
  11. Koga Y, Povalko N, Katayama K, Kakimoto N, Matsuishi T, Naito E, Tanaka M: Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene.　 Brain Dev　2012;34:87-91.
  12. Koga Y,Tanaka M, Ohta S, Wei YH: Biochemistry of Mitochondria, Life and Intervention 2010. Biochim Biophys Acta 2012;1820:551-552.
  13. Ikawa M, Arakawa K, Hamano T, Nagata M, Nakamoto Y, Kuriyama M, Koga Y, Yoneda M: Evaluation of systemic redox states in patients carrying MELAS A3243G mutation in mitochondrial DNA. Eur Neurol 2012;67(4):232-237.
  14. Yatsuga S, Hiromatsu Y, Sasaki S, Nakamura H, Katayama K, Nishioka K, Koga Y: A two-day-old hyperthyroid neonate with thyroid hormone resistance born to a mother with well-controlled Graves’ disease: case report. J Med Case Rep 2012;6(1):246.
  15. Ahlqvist KJ, Hamalainen RH, Yatsuga S, Uutela M, Terzioglu M, Gotz A, Forsstrom S, Salven P, Angers-Loustau A, Kopra OH, Tyynismaa H, Larsson NG, Wartiovaara K, Prolla T, Trifunovic A, Suomalainen A.: Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab 2012;15(1):100-109.
  16. Yatsuga S, Suomalainen S.: Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 2012;21(3):526-535.
  17. Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, Kakuma T, Koga Y, and Matsuoka T：For MELAS Study Group in Japan. : MELAS: A nationwide prospective cohort study of 96 patients in Japan.　 Biochim Biophys Acta　2012;1820:619-624.
  18. Iwata O, Okamura H, Saitsu H, Saikusa M, Kanda H, Eshima N, Iwata S, Maeno Y, Matsuishi T: Diurnal Cortisol Changes in Newborn Infants Suggesting Entrainment of Peripheral Circadian Clock in Utero and at Birth. Clin Endocrinol Metab 2013 Jan;98(1):E25-32.
  19. Iwata S, Nakamura T, Hizume E, Kihara H, Takashima S, Matsuishi T, Iwata O: Qualitative brain MRI at term and cognitive outcomes at 9 years after very preterm birth. Pediatrics 2012;29:e1138-1147.
  20. Iwata S, Iwata O, Iemura A, Iwasaki M, Matsuishi T: Sleep architecture in healthy 5-year-old preschool children: associations between sleep schedule and quality variables. Acta Paediatr 2012;101:e110-114.
  21. Robertson NJ, Kato T, Bainbridge A, Chandrasekaran M, Iwata O, Kapetanakis A, Faulkner S, Cheong J, Iwata S, Hristova M, Cady E, Raivich G: Methyl-isobutyl Amiloride Reduces Brain Lac/NAA, Cell Death and Microglial Activation in a Perinatal Asphyxia Model. J Neurochem 2013 Mar;124(5):645-657.
  22. Iwata O, Nabetani M, Takenouchi T, Iwaibara T, Iwata S, Tamura M: Working Group on Therapeutic Hypothermia for Neonatal Encephalopathy, Ministry of Health, Labor and Welfare, Japan; Japan Society for Perinatal and Neonatal Medicine. Hypothermia for neonatal encephalopathy: Nationwide Survey of Clinical Practice in Japan as of August 2010. Acta Paediatr 2012 May;101(5):e197-202.
  23. Takenouchi T, Iwata O, Nabetani M, Tamura M:　Therapeutic hypothermia for neonatal encephalopathy: JSPNM & MHLW Japan Working Group Practice Guidelines Consensus Statement from the Working Group on Therapeutic Hypothermia for Neonatal Encephalopathy, Ministry of Health, Labor and Welfare (MHLW), Japan, and Japan Society for Perinatal and Neonatal Medicine (JSPNM). Brain Dev 2012 Feb;34(2):165-170.
  24. Iwata O, Takenouchi T:　Past, present and future of hypothermic neuroprotection for neonatal encephalopathy in Japan: time to say good-by to the old remedies. Brain Dev 2012 Feb;34(2):163-164.
  25. Hara M, Inokuchi T, Taniwaki T, Otomo T, Sakai N, Matsuishi T, Yoshino M: An adult patient with mucolipidosis Ⅲalpha/beta presenting with parkinsonism. Brain Dev 2012;35:462-465.
  26. Ono S, Yoshiura K, Kinoshita A, Kikuchi T, Nakane Y, Kato N, Sadamatsu M, Konishi T, Nagamitsu S, Matsuura M, Yasuda A, Komine M, Kanai K, Inoue T, Osamura T, Saito K, Hirose S, Koide H, Tomita H, Ozawa H, Niikawa N, Kurotaki N:　Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions. J Hum Genet 2012 May;57(5):338-341.
  27. Ihara K, Yoshino M, Hoshina T, Harada N, Kojima-Ishii K, Makimura M, Hasegawa Y, Watanabe Y, Yamaguchi S, Hara T: Coagulopathy in patients with late-onset ornithine transcarbamylase deficiency in remission state: a previously unrecognized complication. Pediatrics 2013 Jan;131(1):e327-330.
  28. Mitobe　S, Togawa T, Tsukimura T, Kodama T, Tanaka T, Doi K, Noiri E, Akai Y, Saito Y, Yoshino M, Takenaka T, Saito S, Ohno K, and Sakuraba H: Mutant α-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level. Mol Genet Metab 2012 Nov;107(3):623-626.
  29. Matsufuji M, Utsunomiya H, Inoue T, Yasumoto S, Takashima S, Mitsudome A: Magnetic resonance imaging volumetry and clinical analysis of epilepsy patients with unilateral hippocampal abnormalities. Pediatr Int 2012;54:19-26.
  30. Suefuji N, Niino D, Arakawa F, Karube K, Kimura Y, Kiyasu J, Takeuchi M, Miyoshi H, Yoshida M, Ichikawa A, Sugita Y, Ohshima K: Clinicopathological analysis of composite lymphoma containing both T-and B-cell lymphomas. PatholInt 2012;62:690-698.
  31. Kimura Y, Arakawa F, Kiyasu J, Miyoshi H, Yoshida M, Ichikawa A, Nakashima S, Ishibashi Y, Niino D, Sugita Y, Ishiyama K, Higuchi M, Tasaki Y, Shimomura T, Koike C, Kuwahara N, Fujikawa K, Ohshima K: A spindle cell variant diffuse large B-cell lymphoma is characterized by T-cell/myofibrohistio-rich stromal alternations:analysis of 10 cases and a review of the literature. Eur J Haematol 2012;89:302-310.
  32. Sugita Y, Ohta M, Ohshima K, Niino D, Nakamura Y, Okada Y, Nakashima S: Epstein-Barr virus-positive lymphoproliferative disorder associated with old organized chronic subdural hematoma. Pathol Int 2012;62:412-417.
  33. Miyoshi H, Sato K, Niino D, Arakawa F, Kimura Y, Kiyasu J, Takeuchi M, Yoshida M, Okada Y, Nakamura Y, Sugita Y, Ohshima K: Clinicopathological analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell ltmphoma:Bcl-6 expression might affect progression between these orders. Am J Clin Pathol 2012;137:879-889.
  34. Miyoshi H, Arakawa F, Sato K, Kimura Y, Kiyasu J, Takeuchi M, Yoshida M, Ichikawa A, Ishibashi Y, Nakamura Y, Nakashima S, Niino D, Sugita Y, Ohshima K: Comparison of CD20 expression in B-cell lymphoma between newly diagnosed, untreated cases and those after rituximab treatment. Cancer Sci 2012;103:1567-1573.
  35. Fukushima S, Sugita Y, Niino D, Mihashi H, Ohshima K: Clinicopathological analysis of olfactory neuroblastoma. Brain Tumor Pathol 2012;29:207-215.
  36. Terasaki M, Bouffet E, Maeda M, Sugita Y, Sawamura Y, Morioka M: Successful treatment of leptomeningeal gliomatosis of pilomyxoid astrocytoma after failed fronline chemotherapy. Neurologist 2012;18:32-35.
  37. Abe H, Kawahara A, Sugita Y, Yamaguchi T, Terasaki M, Kage M: Follow-up evaluation of radiation-induced DNA damage in CSF disseminated high-grade glioma using phospho-histone H2AX antibody. Diagnostic Cytopathology 2012:40(5):435-439.
  38. Hashikawa K, Niino D, Yasumoto S, Nakama T, Kiyasu J, Sato K, Kimura Y, Takeuchi M, Miyoshi H, Sugita Y, Hashimoto T, Ohshima K: Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm. J Am Acad Dermatol 2012;66:278-291.
  39. Tanoue R, Ohta K. Ogasawara S, Yano H, Kusukawa J, Nakamura K: Bone marrow stromal cells cause subcutaneous fibroblasts to differentiate into osteocytes in a physically statial micronment in rats. Acta Histochemica 2013;115:512-518.
  40. Nogita H, Ohta K, Hisaka T, Nakayama M, Akashi M, Etoh D, Kawashima Y, Kawahara R, Ishikawa H, Yasunaga M, Horiuchi H, Nakamura K, Kinoshita H, Shirouzu K: Objective Detection for Biliary Tract Carcinoma Using Autofluorescence Imaging. Abdominal Oncology 2013 (in press)
  41. Uemura Y, Qin L, Gotoh K, Ohta K, Nakamura K, Watanabe H：Comparison study of single and concurrent administrations of carbapenem, new quinolone, and macrolide against in vitro nontypeable Haemophilus influenzae mature biofilms. J Infect Chemother 2013 (in press)
  42. Ohta K, Shoji S, Togo A, Higashi R, Tanoue R, Nakamura K: Beam deceleration for block-face scanning electron microscopy of embedded biological tissue. Micron 2012;43:612-620.
  43. Tanoue R, Ohta K, Kusukawa J, Nakamura K: The effect of the microenvironment created by a titanium mesh cage on subcutaneous experimental bone formation and inhibition of absorption. Cells Tissues Organs 2012;196:221-230.
  44. Hashitani H, Mitsui R, Shimizu Y, Higashi R, Nakamura K: Functional and morphological properties of pericytes in suburothelial venules of the mouse bladder. British J Pharmacol 2012;167:1723-1736.
  45. Oba T, Yasukawa H, Hoshijima M, Sasaki KI, Futamata N, Fukui D, Mawatari K, Nagata T, Kyogoku S, Ohshima H, Minami T, Nakamura K, Kang D, Yajima T, Knowlton KU, Imaizumi T: Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol 2012;59:838-852.
  46. Ishibashi Y, Yamagishi S, Matsui T, Ohta K, Tanoue Ryuichiro, Takeuchi M, Ueda S, Nakamura K, Okuda S: Pravastatin inhibits advanced glycation end products (AGEs)‐induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level. Metabolism 2012;61:1067-1072.
  47. Ohta K, Higashi R, Sawaguchi A, Nakamura K: Helical arrangement of filaments in microvillar actin bundles. J Struct Biol 2012;177:513-519.
  48. Hamada N, Nishi Y, Tajiri Y, Hosoda H, Kangawa K, Kojima M,Mifune H: Disrupted regulation of ghrelin production under anti-hypertensive treatment in spontaneously hypertensive rats.　Circ J　2012;76:1423-1429.
  49. Hiraki T, Baker W, Greenberg JH : Effect of vagus nerve stimulation during transient focal cerebral ischemia on chronic outcome in rats. J Neurosci Res 2012;90:887-894.
  50. Sun Z, Baker W, Hiraki T, Greenberg JH : The effect of right vagus nerve stimulation on focal cerebral ischemia:an experimental study in the rat. Brain Stimul 2012;5:1-10.
  51. Ito A, Goto T, Maekawa K, Baba T, Mishima Y, Ushijima K : Postoperative neurological complication and risk factors for pre-existing silent brain infarction in elderly patients undergoing coronary artery bypass grafting. J Anesth 2012;26:405-411.
  52. Cai K, Shore A, Singh A, Haris M, Hiraki T, Waghray P, Reddy DGreenberg JH, Reddy R: Blood oxygen level dependent angiography (BOL Dangio) and its potential applications in cancer research. MNR in Biomedicine 2012;25(10):1125-1132.
  53. Pilkinton DT, Hiraki T, Detre JA, Greenberg JH Reddy R: Absolute cerebral blood flow quantification with pulsed arterial spin labeling during hyperoxia corrected with the simultaneous measurement of the longitudinal relaxation time of arterial blood. Magn Reson Med 2012;67(6):1556-1565.